Keyphrases
In Vitro Liver Model
50%
Intestinal Epithelial Cells
50%
Acetaminophen Hepatotoxicity
50%
Organotypic
50%
Tumor Immunotherapy
50%
Rat Liver Model
50%
Human Hepatic Cells
50%
Immunomodulatory Nanoparticles
50%
Anti-PD-1 Antibody
50%
LL-37
50%
Metastatic Lesions
50%
Polyelectrolyte multilayers
50%
Liver Model
50%
Cell Reprogramming
50%
CGAS-STING
50%
Liver Fibrosis
50%
Synthetic Niche
50%
Clinical Metastasis
50%
Experimental Metastasis
50%
Analysis Mechanisms
50%
Early Pancreatic Cancer
50%
Metastatic Dormancy
50%
Engineered Niche
50%
Cellular Immunotherapy
50%
Connecting Form
50%
Hepatic Stellate Cells
40%
67NR
37%
Liver Sinusoidal Endothelial Cells
37%
PLG Nanoparticles
33%
Anti-PD-1
30%
Killing Activity
27%
Accurately Model
25%
Gastrointestinal Toxicity
25%
Toxic Response
25%
Advanced in Vitro Models
25%
Function Model
25%
Interleukin-15 (IL-15)
20%
Non-gradient
20%
Monoculture
20%
Metastatic Site
20%
Pre-metastatic
18%
Anti-PD-1 Therapy
16%
Extrinsic Apoptosis
16%
Immune Checkpoint Blockade
16%
Ly6C
16%
NK Cell Activity
16%
Tumor-associated Macrophages
16%
Lung Tumor
16%
Nanoparticle Delivery
16%
Spleen Tumor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatotoxicity
100%
Malignant Neoplasm
100%
Metastasis
62%
Transcription Factors
56%
Gastrointestinal Toxicity
50%
Metastasis Potential
50%
Toxicity
50%
Chemical Toxicity
50%
Environmental Chemical
50%
Drug
50%
Breast Cancer
50%
Xenobiotic Agent
50%
Experimental Metastasis
50%
RNA-Sequencing
50%
Immunomodulation
50%
Paracetamol
50%
High-Throughput Screening
25%
Adverse Event
25%
Interleukin 15
25%
Cancer Model
25%
Necrosis
16%
Interleukin 10
16%
Gamma Interferon
16%
CYP2E1
16%
Synergism
16%
Aspartate Aminotransferase
16%
Alanine Aminotransferase
16%
Tumor Necrosis Factor
16%
Glutathione
16%
Chemoattractant
16%
Inosine Phosphate
12%
Neoplasm
12%
Spleen Tumor
8%
Disease
6%
Biological Marker
6%
Receptor
6%
Carcinogenesis
6%
Metastatic Breast Cancer
6%
Mouse
6%
Triple Negative Breast Cancer
6%
Immunology and Microbiology
Immunocompetent Cell
50%
Nuclear Reprogramming
50%
Monocyte
50%
Hepatic Stellate Cell
50%
Cell Killing
50%
Neutrophil Granulocyte
50%
RNA Sequence
50%
Neutrophil Chemotaxis
25%
Cell Proliferation
25%
Mouse
25%
Transcription Factors
25%
Tumor Cell
25%
Cell Migration
25%
Signal Transduction
25%
Neutrophil
25%
Circulating Tumor Cell
25%
Interleukin 15
20%
Single-Cell Sequencing
16%
Immune Checkpoint Blockade
12%
Tumor-Associated Macrophage
12%
Cytotoxic T Cell
12%
Antigen Presentation
12%
Programmed Death-Ligand 1
10%
Glycolic Acid
10%
STAT1
9%
Bacterium Contamination
8%
Biomembrane
8%
Tissue Interaction
8%
Young Modulus
8%
Mannose Receptor
8%
Urokinase Receptor
8%